AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 148 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,242,294 | -61.2% | 1,762,115 | -32.5% | 0.66% | -59.6% |
Q2 2023 | $28,968,355 | +72147.5% | 2,612,115 | 0.0% | 1.62% | -38.5% |
Q1 2023 | $40,096 | -34.6% | 2,612,115 | -5.4% | 2.64% | -35.6% |
Q4 2022 | $61,291 | -99.8% | 2,762,115 | +37.3% | 4.10% | +78.5% |
Q3 2022 | $32,858,000 | +12.4% | 2,012,115 | 0.0% | 2.30% | +3.9% |
Q2 2022 | $29,236,000 | -21.3% | 2,012,115 | 0.0% | 2.21% | -22.5% |
Q1 2022 | $37,164,000 | -22.3% | 2,012,115 | 0.0% | 2.85% | +0.3% |
Q4 2021 | $47,828,000 | -10.2% | 2,012,115 | -6.9% | 2.84% | +31.5% |
Q3 2021 | $53,253,000 | -3.3% | 2,162,115 | -3.0% | 2.16% | +15.7% |
Q2 2021 | $55,070,000 | +2.5% | 2,228,667 | -9.6% | 1.87% | +56.2% |
Q1 2021 | $53,752,000 | -14.5% | 2,464,545 | -0.0% | 1.20% | -20.0% |
Q4 2020 | $62,895,000 | -9.6% | 2,464,547 | -2.0% | 1.50% | -44.0% |
Q3 2020 | $69,538,000 | +2.6% | 2,514,546 | -0.0% | 2.67% | +3.4% |
Q2 2020 | $67,804,000 | – | 2,514,547 | – | 2.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |